Panel testing is not a panacea

Journal of Clinical Oncology

Volumn 34, Issue 13, 2016, Pages 1433-1435

  Axilbund, Jennifer E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; PROTEIN MSH6; PROTEIN P53; UVOMORULIN;

BREAST CANCER; CANCER GENETICS; CANCER MORTALITY; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CLINICAL GENETICS; CLINICAL PRACTICE; DNA SEQUENCE; EDITORIAL; ETHNIC DIFFERENCE; EVIDENCE BASED PRACTICE; FAMILY HISTORY; GASTRECTOMY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; GROUPS BY AGE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; INFORMATION SEEKING; MORBIDITY; MUTATION RATE; NEXT GENERATION SEQUENCING; PANEL TESTING; PATIENT CARE; PRIORITY JOURNAL; SCREENING TEST; STOMACH CANCER; BREAST TUMOR; FEMALE; GENETIC PREDISPOSITION; GENETICS; PROCEDURES;

BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS;

EID: 84965036445     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.65.5522     Document Type: Editorial

References (18)

1. Thompson ER, Rowley SM, Li N, et al: Panel testing for familial breast cancer: Calibrating the tension between research and clinical care. J Clin Oncol 34: 1455-1459, 2016.
2. Tung N, Lin, NU, Kidd J, et al: Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer. J Clin Oncol 34:1460-1468, 20163.
3. Tung N, Battelli C, Allen B, et al: Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer 121:25-33, 2015.
4. Cragun D, Radford C, Dolinsky JS, et al: Panel-based testing for inherited colorectal cancer: A descriptive study of clinical testing performed by a US laboratory. Clin Genet 86:510-520, 2014.
5. Kurian AW, Hare EE, Mills MA, et al: Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. J Clin Oncol 32:2001-2009, 2014.
6. Slavin TP, Niell-Swiller M, Solomon I, et al: Clinical application of multigene panes: Challenges of next-generation counseling and cancer risk management. Front Oncol 5:208, 2015.
7. Bonadies DC, Brierley KL, Barnett RE, et al: Adverse events in cancer genetic testing: The third case series. Cancer J 20:246-253, 2014.
8. Brierley KL, Blouch E, Cogswell W, et al: Adverse events in cancer genetic testing: Medical, ethical, legal, and financial implications. Cancer J 18:303-309, 2012.
9. Giardiello FM, Brensinger JD, Petersen GM, et al: The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 336:823-827, 1997.
10. Antoniou AC, Casadei S, Heikkinen T, et al: Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371:497-506, 2014.
11. Gabai-Kapara E, Lahad A, Kaufman B, et al: Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2. Proc Natl Acad Sci USA 111:14205-14210, 2014.
12. Kluijt I, Sijmons RH, Hoogerbrugge N, et al: Familial gastric cancer: Guidelines for diagnosis, treatment and periodic surveillance. Fam Cancer 11: 363-369, 2012.
13. Li J, Meeks H, Feng BJ, et al: Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiplecase breast and ovarian cancer families. J Med Genet 53:34-42, 2016.
14. Borzekowski DL, Guan Y, Smith KC, et al: The Angelina effect: Immediate reach, grasp, and impact of going public. Genet Med 16:516-521, 2014.
15. Evans DG, Barwell J, Eccles DM, et al: The Angelina Jolie effect: How high celebrity profile can have a major impact on provision of cancer related services. Breast Cancer Res 16:442, 2014.
16. Juthe RH, Zaharchuk A, Wang C: Celebrity disclosures and information seeking: The case of Angelina Jolie. Genet Med 17:545-553, 2015.
17. Leighton JW, Valverde K, Bernhardt BA: The general public's understanding and perception of direct- To-consumer genetic test results. Public Health Genomics 15:11-21, 2012.
18. Robson ME, Bradbury AR, Arun B, et al: American Society of Clinical Oncology policy statement update: Genetic and genomic testing for cancer susceptibility. J Clin Oncol 33:3660-3667, 2015DOI:10.1200/JCO.2015.65.5522;publishedonlineaheadofprintatwww.jco.orgonMarch14, 2016.